You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 19, 2024

MERIDIA Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Meridia, and what generic alternatives are available?

Meridia is a drug marketed by Abbott and is included in one NDA.

The generic ingredient in MERIDIA is sibutramine hydrochloride. There are six drug master file entries for this compound. Additional details are available on the sibutramine hydrochloride profile page.

Drug patent expirations by year for MERIDIA
Recent Clinical Trials for MERIDIA

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
New York State Psychiatric InstitutePhase 4
AstraZenecaPhase 4
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)N/A

See all MERIDIA clinical trials

Paragraph IV (Patent) Challenges for MERIDIA
Tradename Dosage Ingredient Strength NDA ANDAs Submitted Submissiondate
MERIDIA Capsules sibutramine hydrochloride 10 mg and 15 mg 020632 1 2009-08-14

US Patents and Regulatory Information for MERIDIA

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Abbott MERIDIA sibutramine hydrochloride CAPSULE;ORAL 020632-001 Nov 22, 1997 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Abbott MERIDIA sibutramine hydrochloride CAPSULE;ORAL 020632-002 Nov 22, 1997 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Abbott MERIDIA sibutramine hydrochloride CAPSULE;ORAL 020632-003 Nov 22, 1997 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for MERIDIA

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Abbott MERIDIA sibutramine hydrochloride CAPSULE;ORAL 020632-003 Nov 22, 1997 ⤷  Try a Trial ⤷  Try a Trial
Abbott MERIDIA sibutramine hydrochloride CAPSULE;ORAL 020632-001 Nov 22, 1997 ⤷  Try a Trial ⤷  Try a Trial
Abbott MERIDIA sibutramine hydrochloride CAPSULE;ORAL 020632-002 Nov 22, 1997 ⤷  Try a Trial ⤷  Try a Trial
Abbott MERIDIA sibutramine hydrochloride CAPSULE;ORAL 020632-002 Nov 22, 1997 ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

International Patents for MERIDIA

See the table below for patents covering MERIDIA around the world.

Country Patent Number Title Estimated Expiration
Australia 6644286 ⤷  Try a Trial
Czechoslovakia 259545 METHOD OF N,N-DIMETHYL-1-(1-/CHLORPHENYL/ CYCLOBUTYL)-3-METHYLBUTYL-AMIN-HYDROCHLORIDE'S MONOHYDRATE PRODUCTION ⤷  Try a Trial
Ireland 863102 ⤷  Try a Trial
European Patent Office 0230742 N,N-DIMETHYL-1-(1-(4-CHLOROPHENYL)CYCLOBUTYL)-3-METHYLBUTYLAMINE HYDROCHLORIDE MONOHYDRATE AND PHARMACEUTICAL COMPOSITIONS CONTAINING IT ⤷  Try a Trial
>Country >Patent Number >Title >Estimated Expiration

Supplementary Protection Certificates for MERIDIA

Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
0397831 01C0052 France ⤷  Try a Trial PRODUCT NAME: CHLORHYDRATE DE SIBUTRAMINE MONOHYDRATE; REGISTRATION NO/DATE IN FRANCE: NL 23289 DU 20010613; REGISTRATION NO/DATE AT EEC: IKS 54770 DU 19990113
0397831 SPC/GB01/053 200210 United Kingdom ⤷  Try a Trial
0397831 34/2001 Austria ⤷  Try a Trial PRODUCT NAME: SIBUTRAMINHYDROCHLORID; NAT. REGISTRATION NO/DATE: 1-24052, 1-24053 20010423; FIRST REGISTRATION: LI 54770 19990113
0397831 300066 Netherlands ⤷  Try a Trial PRODUCT NAME: SIBUTRAMINE HYDROCHLORIDE, IN HET BIJZONDER SIBUTRAMINE HYDROCHLORIDE MONOHYDRAAT; NATL. REGISTRATION NO/DATE: RVG 26281 RVG 26282 20010404; FIRST REGISTRATION: DE 41531.00.00 41531.01.00 41533.01.00 19990114; CH IKS 54770 19990113
>Patent Number >Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.